Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • zwerp2000 zwerp2000 Sep 26, 2013 8:46 AM Flag

    Data confirms the need to get this approved.

    Remember, SRPT's main competition has been eliminated right now. Therefore, the argument that if drisp is approved first will impact sales along with the impact of the patent issue in Europe has been removed. The stock should be trading higher.

 
SRPT
14.19+0.39(+2.83%)Apr 29 4:00 PMEDT